Supply chain crisis puts a strain on stores to keep necessities like baby formula as supplies are strained due to manufacturing, packaging, and transportation.
A lawsuit against Bill Gates, the Indian government and others, citing extensive case law, is attracting renewed scrutiny of Gates and his long-term, controversial involvement in India’s vaccine program.
The Supreme Court on Thursday blocked the Biden administration’s COVID-19 vaccine mandate for private businesses but decided to let a separate regulation that requires health care workers to get a vaccine take effect.
Despite the FDA’s claim that it is committed to transparency, especially for COVID-19 emergency use authorizations (EUAs), the agency first requested 55 years to release the data supporting the approval of Comirnaty after a Freedom of Information Act (FOIA) request was led, and then asked for an extra 20 years to fully comply.
According to a recent report, Apple has increased its reliance on Communist Chinese suppliers and appears to be replacing Taiwanese manufacturer Foxconn with Chinese supplier Luxshare as part of its $275 billion deal with the Communist government.
COVID-19 vaccine manufacturer Pfizer Inc. says they're “proud to stand with China” in connection with the use of the Chinese Communist Party’s payment platform, which is being used for vaccine passports.
The World Council for Health, which describes itself as a "worldwide coalition of health-focused organizations and civil society groups that seek to broaden public health knowledge and sense-making through science and shared wisdom," has released a declaration demanding governments and organizations to put "an immediate stop" to the distribution of COVID vaccines all over the world.
Another 205,000 American workers filed for unemployment benefits last week, matching the prior week’s jobless claims number and roughly in line with pre-pandemic levels, suggesting that the recent rise in COVID-19 infections was not driving a fresh wave of layoffs.
Later this week, the FDA plans to approve, as the first outpatient COVID drugs, therapeutics that are extremely dangerous and unproven, even as the agency goes to war against cheap, safe, and proven drugs with a track record of no serious adverse events.
